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Among 777 endometrial cancer cases and 1550 controls from Italy and Switzerland, odds ratio was 1.7 (95% confidence interval:
1.2–2.5) for diabetes, and 5.1 for obese diabetic women as compared with non-obese non-diabetic ones. Diabetes shows a
supramultiplicative effect with body mass index, but not with physical activity or hypertension.
British Journal of Cancer (2007) 97, 995–998. doi:10.1038/sj.bjc.6603933 www.bjcancer.com
Published online 2 October 2007
& 2007 Cancer Research UK
Keywords: case–control study; endometrial cancer; diabetes; body mass index; physical activity; hypertension
                                  
An increased risk of endometrial cancer in diabetic women has
often been reported (Parazzini et al, 1991, 1999; Brinton et al, 1992;
La Vecchia et al, 1994; Shoff and Newcomb, 1998; Salazar-Martinez
et al, 2000; Weiderpass et al, 2000; Anderson et al, 2001; Sharma
et al, 2001; Cook et al, 2006; Friberg et al, 2007). Overweight and
obesity are major risk factors for both conditions since they are
related to increased endogenous oestrogen levels (Parazzini et al,
1991; Calle et al, 2003; Cook et al, 2006). Although the association
between diabetes and endometrial cancer may be partly or largely
accounted for by the higher body weight of endometrial cancer
cases, it has been found to persist after adjustment for body mass
index (BMI) (Brinton et al, 1992; La Vecchia et al, 1994; Parazzini
et al, 1999; Salazar-Martinez et al, 2000; Friberg et al, 2007).
A few of the above studies have investigated the combined role of
diabetes and BMI on risk, finding a higher risk among obese diabetic
women, most of these, but not all (Anderson et al, 2001), reporting
some excess risk also among non-overweight diabetic women.
Diabetes is associated with hypertension and physical inactivity,
which in turn have been related to endometrial cancer risk
(Parazzini et al, 1999; Cust et al, 2007; Voskuil et al, 2007). In a
Swedish cohort study of 225 cases of endometrial cancer, the
relative risk was 2.7 for diabetic women reporting low physical
activity and 1.1 among those reporting high physical activity
(Friberg et al, 2007). In an Italian case–control study, the
association with diabetes was of similar magnitude in women
with or without hypertension (Parazzini et al, 1999).
We therefore investigated whether the association between
diabetes and endometrial cancer was modified by BMI, physical
activity and hypertension in two case–control studies from Italy
and Switzerland.
MATERIALS AND METHODS
We analysed the combined data of two case–control studies of
endometrial cancer, the first conducted in the greater Milan area and
the Swiss Canton of Vaud between 1988 and 1994 on 410 cases and
753 controls (Augustin et al, 2003), the second conducted in the
provinces of Pordenone and Milan, in northern Italy, and Naples, in
southern Italy, in 1992–2006 on 454 cases and 908 controls. A subset
from the latter included in a previous study was excluded (Dal Maso
et al, 2004). This left a total of 777 women (aged 18–79 years, median
61 years) with histologically confirmed endometrial cancer, with no
previous diagnosis of cancer, and 1550 control women (aged 18–80
years, median 61 years) admitted to the same network of hospitals as
cases for acute, non-neoplastic, and non-gynaecologic, non-
hormone-related, non-metabolic conditions. Women with a history
of hysterectomy were excluded from the control group. Fewer than
5% of subjects approached for interview refused to participate.
For both cases and controls, data were collected by trained
interviewers during their hospital stay using similar structured
questionnaires covering education, socio-economic factors, life-
style habits, anthropometric measures and physical activity at
various ages, a validated food-frequency section, menstrual and
reproductive history, and use of oral contraceptive (OC) and
hormone replacement therapy (HRT). Details were also collected
on personal medical history, including diabetes and hypertension.
Body mass index at diagnosis and at age 30–39 years were
computed as weight/height
2 (kgm
 2); physical activity at age
30–39 years was considered.
Odds ratios (OR) according to history of diabetes and
corresponding 95% confidence intervals (CIs), were estimated
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terms for age, year of interview, study centre, years of education,
parity, menopausal status, OC and HRT use, plus BMI, physical
activity and history of hypertension when appropriate. To test for
heterogeneity, we compared the differences between the  2log
likelihood of the models with and without interaction term with
the w
2 distribution with one degree of freedom.
RESULTS
Table 1 shows the distribution of 777 endometrial cancer cases and
1550 controls according to age, history of diabetes, BMI at
diagnosis, BMI at age 30–39 years, physical activity at age 30–39
years and history of hypertension, and the corresponding ORs. By
design, cases and controls had similar age distribution. Cases
reported more frequently than controls a history of diabetes (9.9 vs
4.6%), with an OR of 1.7 (95% CI: 1.2–2.5) after detailed
adjustment for BMI at diagnosis. The OR for diabetes was 2.0
(95% CI: 1.4–2.9) in the absence of adjustment for BMI, and 1.9
(95% CI: 1.3–2.7) when a term for BMI at age 30–39 was included
in the model. The OR was 2.4 (95% CI: 1.9–3.1) for women with a
BMI at diagnosis X30kgm
 2, 1.6 (95% CI: 1.3–2.0) for women
with a BMI at age 30–39 X25kgm
 2, 1.4 (95% CI: 1.1–1.8) for
women with a low level of physical activity at age 30–39, and 1.2
(95% CI: 1.0–1.5) for women with a history of hypertension.
Table 2 considers the combined effect of diabetes with BMI at
diagnosis, BMI at age 30–39, physical activity at age 30–39, and
history of hypertension. Compared with non-diabetic non-obese
women (BMI at diagnosis o30kgm
 2), the OR was 1.4 for non-
obese women with diabetes, but rose to 5.1 for obese diabetic
women. Corresponding ORs for women with diabetes were 1.8
with BMI at age 30–39 years o25kgm
 2, and 3.4 with BMI at age
30–39 years X25kgm
 2. However, the interaction between
diabetes and BMI at diagnosis or at 30–39 years was not
statistically significant. As compared with non-diabetic women
with moderate or high physical activity, the OR was similar in
diabetic women reporting moderate/high (OR¼1.9) or low
physical activity (OR¼2.0). Similarly, the ORs were comparable
in diabetic women without (OR¼1.8) and with (OR¼2.1) a
history of hypertension, as compared with non-diabetic women
with no hypertension.
The relation between diabetes and endometrial cancer risk was
also examined in strata of age, menopausal status, parity, OC and
HRT use, but no meaningful differences in risk emerged.
DISCUSSION
This large case–control study on endometrial cancer confirms and
provides further quantitative evidence that diabetes is indepen-
dently related to endometrial cancer risk. The association was
partly, but not totally, explained by overweight. As in other
epidemiological studies (Shoff and Newcomb, 1998; Salazar-
Martinez et al, 2000; Anderson et al, 2001; Friberg et al, 2007),
the association with diabetes was stronger for obese women,
suggesting a supramultiplicative effect between diabetes and
obesity in endometrial cancer risk.
Of particular interest, our information on BMI at both diagnosis
and in the distant past allowed us to show a significant association
between diabetes and endometrial cancer for women who were not
overweight at age 30–39. The combination of diabetes and
overweight in young/middle age is compatible with a multiplicative
model for exposure to both factors on the relative risk of
endometrial cancer. However, these subgroup analyses were
affected by large random variation, so we could not distinguish
between different models.
Type II diabetes is related to hyperinsulinaemia, which may
increase free oestrogen levels by decreasing the concentration of
sex hormone-binding globulin (Nestler et al, 1991; Friberg et al,
2007). Hyperinsulinaemia may also influence the insulin –growth
factor (IGF) system. Increasing levels of IGF-1 (Weiderpass et al,
2003) and of IGF-binding protein-1 (Augustin et al, 2004) have
been associated with endometrial cancer risk, particularly in older
overweight women. Overweight and obesity have also been related
to low levels of the insulin sensitiser adiponectin, and conse-
quently to increased risk of hyperinsulinaemia and type II diabetes
(Mantzoros et al, 2005). An inverse association has also been
shown between adiponectin levels and endometrial cancer risk
(Dal Maso et al, 2004). These mechanisms do not only explain the
association between diabetes and endometrial cancer, but also
provide a background for a positive interaction with overweight.
The Swedish Mammography Cohort Study (Friberg et al, 2007)
found a strongly positive interaction between diabetes and low
physical activity, and endometrial cancer risk, the relative risk for
obese diabetics report low physical activity being 9.6. In our study,
however, the association with diabetes was not modified by
physical activity. This apparent difference may be due to different
measures of the physical activity level in various populations, and
also to the play of chance, because the two strata of physical
activity in the Swedish study included 5 and 17 diabetic cases only.
Likewise, with reference to hypertension, we were able to confirm
the absence of a meaningful interaction with diabetes (Parazzini
et al, 1999).
This is a hospital-based case–control study with some of the
related weaknesses and strengths. Diabetics may be more frequently
admitted to hospital, although we excluded from the comparison
group all women hospitalised for chronic and metabolic conditions.
Furthermore, the 4.6% prevalence of diabetes in middle age and
elderly women in our comparison group is similar to that of
Table 1 Distribution of 777 cases of endometrial cancer and 1550
controls according to age, history of diabetes and other selected variables.
Italy and Switzerland, 1988–2006
Characteristic
Case number
(%)
Control number
(%) OR
a (95% CI)
Age (years)
o40 24 (3.1) 73 (4.7)
40–49 75 (9.6) 174 (11.2)
50–59 233 (30.0) 444 (28.6)
60–69 312 (40.1) 589 (38.0)
X70 133 (17.1) 270 (17.4)
History of diabetes
No 700 (90.1) 1479 (95.4) 1
b
Yes 77 (9.9) 71 (4.6) 1.7 (1.2–2.5)
BMI at diagnosis (kgm
 2)
c
o 30 555 (71.8) 1325 (85.89) 1
b
X30 218 (28.2) 222 (14.2) 2.4 (1.9–3.1)
BMI (kgm
 2) at age 30–39
c
o 25 532 (71.2) 1152 (79.6) 1
b
X25 215 (28.8) 295 (10.4) 1.6 (1.3–2.0)
Physical activity at age 30–39
c
Moderate/high 543 (70.2) 1219 (79.2) 1
b
Low 230 (29.7) 321 (20.8) 1.4 (1.1–1.8)
History of hypertension
No 519 (66.8) 1169 (75.4) 1
b
Yes 258 (33.2) 381 (24.6) 1.2 (1.0–1.5)
BMI, body mass index; CI, confidence interval; HRT, hormone replacement therapy;
OC, oral contraceptive; OR, odds ratio.
aEstimates from logistic regression models,
including terms for the above factors plus year of interview, study centre, education,
parity, menopausal status, OC and HRT use.
bReference category.
cThe sum does not
add up to the total because of some missing values.
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interview setting allowed collection of comparable medical history
details, which were shown to be satisfactorily reproducible for
diabetes (k¼0.85) (Bosetti et al, 2001). Furthermore, cases and
controls came from similar catchment areas, and participation rate
was almost complete (approximately 95% for cases and controls).
We were also able to allow for confounding by major hormonal and
reproductive factors for endometrial cancer, and for BMI, not only
at diagnosis but also in the past.
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